Anemia during pregnancy is a common occurrence and often due to iron deficiency. It is a global public health problem, ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has been assigned an average rating of “Buy” from the ten ratings firms ...
Most of us have had to deal with burned spots on our irons. There are many ways to deal with them, and one way features a ...
Disc Medicine (IRON – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 25. Analyst Rami ...
Disc Medicine is in strong financial shape, advancing key candidates. Find out why IRON stock could be a strong investment ...
WATERTOWN, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) shares saw strong trading volume on Thursday after Stifel Nicolaus raised their price target on the stock from $90.00 to $94.00. Stifel Nicolaus ...
Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of ...